fda sued over tirzepatide The Outsourcing Facilities Association (OFA) is suing the after the agency removed (Zepbound, Mounjaro) from the federal drug shortage list without proper notice. The lawsuit claims that the FDA failed Compounders protest as FDA removes

Hidradenitis suppurativa is a lesion-causing inflammatory disorder that affects at least 1 in 100 people and is strongly associated with obesity.

One reason for the large difference between the headline Reta number (12 mg, -26.1% pbo-adjusted) and the ITT number (-21.1%) is probably a high overall patient drop-out rate

Taylor is ASAMs President-Elect andis board-certified in general psychiatry, child and adolescent psychiatry, addiction psychiatry, and addiction medicine

From historic landmarks to hidden gems, we've got you covered

Therapists share practical strategies for protecting your mental health, navigating body changes, and building sustainable habits.

Gua completa con recomendaciones nutricionales basadas en evidencia, alimentos problemticos y cundo consultar a su mdico durante el tratamiento con Mounjaro o Zepbound.